A major cause of death and disability in patients with diabetes mellitus is atherosclerosis. Endothelial dysfunction is an important, if not primary, factor in atherogenesis. Among the substances normally synthesized and released by the endothelium is nitric oxide. Endothelium-dependent vasorelaxation, mediate by nitric oxide, is impaired in experimental models of diabetes and in patients with insulin-dependent (IDDM) and non-insulin- dependent diabetes mellitus (NIDDM). Reactive oxygen species, such as superoxide anions, inactivate nitric oxide in experimental models of diabetes and may contribute to alterations in vasomotor reactivity. This proposal plans to examine the effect of acute and chronic administration of the antioxidants, vitamin C and vitamin E, on vasodilator reactivity in peripheral and coronary vessels of patients with diabetes mellitus (both IDDM and NIDDM) and healthy, age-matched control subjects. To determine whether acute and long-term treatment with antioxidant vitamins favorably affects nitric oxide-mediated vasodilation, coronary artery endothelial function will be assessed by intracoronary infusion of acetylcholine in patients with diabetes mellitus undergoing cardiac catheterization. Acute studies will be performed prior to and immediately following intracoronary administration of vitamin C or placebo. Long-term studies will be obtained six months following randomization to vitamins E and C, or corresponding placebo. In addition, peripheral conduit artery endothelial function will be studied noninvasively by vascular ultrasound in healthy subjects and patients with IDDM and NIDDM. Acute studies will be performed prior to and 2 hours after administration of oral vitamin C. Long-term studies will be performed six months following randomization to vitamin C and E or placebo. It is anticipated that results from these studies will give mechanistic insight into a cause of abnormal endothelial function in diabetes mellitus, and yield a treatment strategy that may reduce morbidity and mortality from atherosclerosis in this population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056607-04
Application #
6183461
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Linder, Barbara
Project Start
1997-05-01
Project End
2001-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
4
Fiscal Year
2000
Total Cost
$225,741
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Beckman, Joshua A; Creager, Mark A (2006) The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 16:156-62
Beckman, Joshua A; Liao, James K; Hurley, Shauna et al. (2004) Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res 95:217-23
Beckman, Joshua A; Goldfine, Allison B; Gordon, Mary Beth et al. (2003) Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 285:H2392-8
Luscher, Thomas F; Creager, Mark A; Beckman, Joshua A et al. (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 108:1655-61
Creager, Mark A; Luscher, Thomas F; Cosentino, Francesco et al. (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108:1527-32
Beckman, Joshua A; Goldfine, Allison B; Gordon, Mary Beth et al. (2002) Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90:107-11
Beckman, J A; Goldfine, A B; Gordon, M B et al. (2001) Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103:1618-23